1. Home
  2. BNGO vs NNVC Comparison

BNGO vs NNVC Comparison

Compare BNGO & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNGO
  • NNVC
  • Stock Information
  • Founded
  • BNGO 2003
  • NNVC 2005
  • Country
  • BNGO United States
  • NNVC United States
  • Employees
  • BNGO N/A
  • NNVC N/A
  • Industry
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • NNVC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNGO Industrials
  • NNVC Health Care
  • Exchange
  • BNGO Nasdaq
  • NNVC Nasdaq
  • Market Cap
  • BNGO 24.3M
  • NNVC 24.1M
  • IPO Year
  • BNGO 2018
  • NNVC N/A
  • Fundamental
  • Price
  • BNGO $3.88
  • NNVC $1.42
  • Analyst Decision
  • BNGO Buy
  • NNVC
  • Analyst Count
  • BNGO 5
  • NNVC 0
  • Target Price
  • BNGO $7.67
  • NNVC N/A
  • AVG Volume (30 Days)
  • BNGO 159.3K
  • NNVC 124.3K
  • Earning Date
  • BNGO 08-14-2025
  • NNVC 09-26-2025
  • Dividend Yield
  • BNGO N/A
  • NNVC N/A
  • EPS Growth
  • BNGO N/A
  • NNVC N/A
  • EPS
  • BNGO N/A
  • NNVC N/A
  • Revenue
  • BNGO $27,426,000.00
  • NNVC N/A
  • Revenue This Year
  • BNGO N/A
  • NNVC N/A
  • Revenue Next Year
  • BNGO $20.81
  • NNVC N/A
  • P/E Ratio
  • BNGO N/A
  • NNVC N/A
  • Revenue Growth
  • BNGO N/A
  • NNVC N/A
  • 52 Week Low
  • BNGO $2.68
  • NNVC $0.94
  • 52 Week High
  • BNGO $30.52
  • NNVC $1.92
  • Technical
  • Relative Strength Index (RSI)
  • BNGO 58.90
  • NNVC 42.62
  • Support Level
  • BNGO $3.69
  • NNVC $1.40
  • Resistance Level
  • BNGO $4.38
  • NNVC $1.54
  • Average True Range (ATR)
  • BNGO 0.30
  • NNVC 0.07
  • MACD
  • BNGO 0.05
  • NNVC -0.01
  • Stochastic Oscillator
  • BNGO 64.29
  • NNVC 33.91

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: